ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia
Alexandria TM Lee,1 Saihong Ignatius Ou1,2 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence: Saihong Ignatius Ou, University of California Irvine School of Medicine, Department of Med...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2023-07-01
|
| Seria: | Lung Cancer: Targets and Therapy |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.dovepress.com/alesia-5-year-update-alectinib-at-600-mg-twice-daily-gives-lorlatinib--peer-reviewed-fulltext-article-LCTT |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|